Tiziana Life Sciences (TSLA) Develops TZLS-50 to Treat COVID-19 Patients with at Risk of Respiratory Failure

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. META

Go back to Tiziana Life Sciences (TSLA) Develops TZLS-50 to Treat COVID-19 Patients with at Risk of Respiratory Failure
(NASDAQ: TLSA) Delayed: 1.10 -0.03 (2.65%)
Previous Close $1.13    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.17    P/E N/A 
Day Low $1.04    EPS $ 
Volume 423,514